Cite
13-Acetoxysarcocrassolide Exhibits Cytotoxic Activity against Oral Cancer Cells through the Interruption of the Keap1/Nrf2/p62/SQSTM1 Pathway: The Need to Move Beyond Classical Concepts
MLA
Yi-Chang Liu, et al. “13-Acetoxysarcocrassolide Exhibits Cytotoxic Activity against Oral Cancer Cells through the Interruption of the Keap1/Nrf2/P62/SQSTM1 Pathway: The Need to Move Beyond Classical Concepts.” Marine Drugs, vol. 18, no. 8, July 2020, p. 382. EBSCOhost, https://doi.org/10.3390/md18080382.
APA
Yi-Chang Liu, Bo-Rong Peng, Kai-Cheng Hsu, Mohamed El-Shazly, Shou-Ping Shih, Tony Eight Lin, Fu-Wen Kuo, Yi-Cheng Chou, Hung-Yu Lin, & Mei-Chin Lu. (2020). 13-Acetoxysarcocrassolide Exhibits Cytotoxic Activity against Oral Cancer Cells through the Interruption of the Keap1/Nrf2/p62/SQSTM1 Pathway: The Need to Move Beyond Classical Concepts. Marine Drugs, 18(8), 382. https://doi.org/10.3390/md18080382
Chicago
Yi-Chang Liu, Bo-Rong Peng, Kai-Cheng Hsu, Mohamed El-Shazly, Shou-Ping Shih, Tony Eight Lin, Fu-Wen Kuo, Yi-Cheng Chou, Hung-Yu Lin, and Mei-Chin Lu. 2020. “13-Acetoxysarcocrassolide Exhibits Cytotoxic Activity against Oral Cancer Cells through the Interruption of the Keap1/Nrf2/P62/SQSTM1 Pathway: The Need to Move Beyond Classical Concepts.” Marine Drugs 18 (8): 382. doi:10.3390/md18080382.